PCN9 Economic Evaluation of Panitumumab vs Cetuximab in Patients with Colorectal Carcinoma (CRCM) with Non-Mutated (WILD-TYPE) Kras After Failure of Chemotherapy Regimens in Mexico
Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.1570
https://www.valueinhealthjournal.com/article/S1098-3015(11)03132-9/fulltext
Section Title :
Cancer
Section Order :
1515
First Page :
A544
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)03132-9&doi=10.1016/j.jval.2011.08.1570